RVTY vs DGX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RVTY · Revvity$155.11 ▲ 2.84%
DGX · Quest Diagnostics$255.63 ▲ 0.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RVTY +68.4%
- DGX +40.5%
Head to head
| Metric | RVTY | DGX |
|---|---|---|
| Price | $155.11 | $255.63 |
| Change today | ▲ 2.84% | ▲ 0.35% |
| Market cap | $17.31B | $28.12B |
| Return, 3 months | +33.7% | +7.6% |
| Return, year to date | +60.6% | +49.2% |
| Return, 1 year | +71.2% | +44.3% |
| P/E (TTM) | 69.2 | 25.5 |
| P/B | 2.4 | 3.7 |
| P/E percentile vs own 5y | 87th | 99th |
| Dividend yield | 0.18% | 1.32% |
| Revenue growth (YoY, latest qtr) | +4.3% | +10.0% |
| Net profit growth (YoY) | +33.5% | +25.9% |
| Gross margin | 55.9% | 33.1% |
| Operating margin | 12.6% | 14.6% |
| Net margin | 8.6% | 9.5% |
| Return on equity | 3.5% | 15.1% |
| Analyst target vs. price | +13.7% | +1.5% |
| Analyst buy share | 55% | 43% |
| RSI (14) | 51 | 67 |
| 30-day volatility | 42.4% | 21.8% |
| Max drawdown, 1 year | -30.1% | -11.6% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DGX is the largest of the group by market value.
- RVTY has returned the most over the past year.
- DGX carries the lowest trailing P/E.
- DGX pays the highest dividend yield.
- DGX is growing revenue fastest.
- DGX keeps the most profit per dollar of sales.
- DGX has been the calmest stock over the last 30 days.